Company intelligence / Profile preview

Kap Code

Ownership: Private
Development stage: Commercial

Overview

Kap Code has developed and commercialized digital platforms such as Detec't for real-time pharmacovigilance and patient experience analysis using AI-driven social media listening. The company also offers eHealth solutions like W'asm to support chronic disease management. No traditional clinical results as the focus is on digital tools rather than therapeutics.

Therapeutic areas: OtherPulmonology
Modalities: Device (digital health platform)Non-pharmacological therapy (digital intervention)
Industry: Digital Health Medical Devices

Partnerships

Prairie Institute ecosystemTechToMedKappa Santé

Beyond the preview

Go deeper on Kap Code.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kap Code.

Explore the full profile